NextWave Pharmaceuticals

Patent cliffs & loss of exclusivity

A company developing drug delivery technology products

Company

AngelList URLhttps://angel.co/nextwave-pharmaceuticals
Company Operating StatusAcquired
Crunchbase URLhttps://www.crunchbase.com/organization/nextwave-pharmaceuticals
Facebook URLhttps://www.facebook.com/TrisADHD/
Pitchbook URLhttps://pitchbook.com/profiles/company/42831-37
Seedtable URLhttps://seedtable.com/companies/nextwave-pharmaceuticals
Official Websitehttp://www.nextwavepharma.com
Wellfound IDnextwave-pharmaceuticals

3 upcoming patent cliffs

DrugIngredientTypeCliff
  1. QUILLICHEW ERMETHYLPHENIDATE HYDROCHLORIDESmall mol.Aug 2033
  2. QUILLICHEW ERMETHYLPHENIDATE HYDROCHLORIDESmall mol.Aug 2033
  3. QUILLICHEW ERMETHYLPHENIDATE HYDROCHLORIDESmall mol.Aug 2033

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

NextWave Pharmaceuticals — patent cliffs & loss of exclusivity | CliffBio